Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
32 /100
MEDIUM RISK
Score updated Oct 13, 2026

SNDX — Syndax Pharmaceuticals, Inc. Dilution Risk Tracker

Track SNDX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SNDX — Get alerts when the score changes →

As of October 13, 2026, Syndax Pharmaceuticals, Inc. (SNDX) has a DilutionWatch DilutionScore of 32/100, rated MEDIUM dilution risk. Syndax Pharmaceuticals, Inc. has a market capitalization of $1.48B, 89.30M shares outstanding, 246 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
10
📊 Float Risk
20
⚠️ Warrant Exposure
40
🔄 Convertible Debt
60

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 20%
🔁 Convertible Conversion model 40%
• Significant convertible debt: 16% potential dilution
• Elevated convertible risk (60/100)
🔔 Track SNDX — Get forecast alerts →

Market Data

Market Cap$1.48B
Shares Outstanding89.30M
Float79.03M
Cash$547.86M
Debt$344.03M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore32/100DilutionWatch score record
Shares Outstanding89.30MVerified float table or market cache
Public Float79.03MVerified float table or market cache
Market Cap$1.48BMarket data cache
Cash Runway24.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 12.6% shares (2026Q1 vs prior)
246 institutional holders · 120.03M shares
#1 GOLDMAN SACHS GROUP INC 10.69M shares
#2 BlackRock, Inc. 8.25M shares
#3 Kynam Capital Management, LP 8.05M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest18.23M
Days to Cover8.5
% of Float23.1%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-08-04
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual SNDX Dilution Snapshot

Syndax Pharmaceuticals, Inc. (SNDX) has a DilutionScore of 32/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

SNDX's DilutionScore is currently 32/100 (Medium risk), with 2 score changes tracked over 89 days. The score improved from 28/100 (Medium risk).

Period Score Risk Level Duration
Oct 10 – Oct 13, 202632/100MEDIUM4 days
Aug 22 – Oct 09, 202628/100MEDIUM49 days
Jul 16 – Aug 21, 202637/100MEDIUM36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

SNDX shares outstanding have increased 0.1% from 88.51M (May 2026) to 88.61M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 18, 202688.61M79.03M▲ 6.58%
May 15, 202688.61M74.15M▼ 1.26%
May 07, 202688.61M75.10M▲ 0.08%
May 02, 202688.51M75.04M▲ 0.46%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track SNDX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment SNDX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking SNDX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for SNDX
SNDX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.